The story · written by gpt-6,
Rwanda opened a licensing system for medical and research cannabis on 28 June 2021. Growers, processors and researchers could apply to operate under strict security rules, while medical use required a prescription from a specially authorised doctor. The order covered cultivation, products and cross-border trade.
A previous law supplied the authority
The 2012 drug-control law had already allowed authorisations for medical and research activities. The new order, signed by Health Minister Daniel Ngamije Madandi and sealed by Justice Minister Johnston Busingye, supplied detailed rules specifically for cannabis.
It applied to public and private establishments involved in cultivation, processing, distribution and use. Investors and other applicants could seek permission for medical or research purposes. Licences lasted five years and could be renewed.
Growing and trading required separate permissions
The order listed eight types of licence, permit or certificate. These covered growing, processing, research, importing and exporting planting material, importing and exporting cannabis products, and registering finished products.
A cultivation licence included developing genetic material. Bringing in seeds or other planting material required an import permit, and finished products needed registration before entering the market. Product imports and exports also required a permit for each shipment.
Medical use had a prescribing condition: the doctor needed written authority from the health ministry to prescribe cannabis and cannabis products. This made both the medicine and the prescriber part of the controls.
Farms had to secure the crop
Operators had to submit a security plan for police approval. Requirements included double fencing, patrols between the fences, round-the-clock private security, cameras, lighting, watchtowers and an intrusion alarm.
People entering the facilities had to wear protective clothing without pockets. Operators also had to document the supply chain, keep records and submit reports. Transport had to be carried out by the operator or a licensed company authorised by police, with cargo tracking.
Building the industry took longer
In May 2025, the Rwanda Development Board reported that off-site infrastructure for the Musanze cannabis project was 83% complete, with double fencing still outstanding. Reporting described King Kong Organics Rwanda’s licensed project as aimed mainly at producing oils for export.
Alongside this licensed activity, the criminal rules continued to punish unauthorised use, possession and supply. In Rwanda, the 2021 order gave medical businesses, researchers and authorised prescribers a detailed set of conditions to meet.[1][2][3][4]
Listed for context. No score change is recorded for Rwanda here.
References
- Rwanda Official Gazette — cannabis and cannabis products order 2021Articles 1–24; definitions and authorised prescribers, Articles 2 and 14; commencement Article 24archived
- Rwanda Official Gazette — narcotic drugs law 2012Articles 6–7 on prohibition, authorisation and security rules; Article 31 commencementarchived
- Rwanda Ministry of Justice — criminal-law amendment 2019Article 11, possession/use and separate supply offencesarchived
- Eastleigh Voice — Rwanda's medical cannabis project at 83 per cent completion15 May 2025; RDB report to parliament on off-site infrastructure and remaining fencing workarchived
Checked. The date and the event were compared with a source that was read.